M&M was the top gainer in the
Sensex pack, jumping around 6 per cent, followed by Titan, HCL Tech, Tata
Steel, Infosys and TCS.
On
the other hand, Axis Bank, HUL, Kotak Bank and Bharti Airtel were among the
laggards.
Equity benchmark BSE Sensex rallied 429 points on
Thursday on widespread buying amid a broad upmove in global markets following
encouraging COVID-19 vaccine trials.
After soaring 600 points during the session, the 30-share
index settled 429.25 points, or 1.21 per cent, higher at 35,843.70.
The NSE Nifty surged
121.65 points, or 1.17 per cent, to close at 10,551.70.
M&M was the top gainer
in the Sensex pack, jumping around 6 per cent, followed by Titan, HCL Tech,
Tata Steel, Infosys and TCS.
On the other hand, Axis
Bank, HUL, Kotak Bank and Bharti Airtel were among the laggards.
According to Narendra
Solanki, head- equity research (fundamental), Anand Rathi, market rallied
tracking positive Asian peers on news that Germany's BioNTech and US
pharmaceutical giant Pfizer reported positive preliminary results from a joint
project for a potential coronavirus vaccine.
Further, positive factory
output data across economies too boosted global investors' risk appetite,
traders said.
Bourses in Shanghai, Hong
Kong, Tokyo and Seoul ended with significant gains.
International oil benchmark
Brent crude futures rose 0.86 per cent to $42.39 per barrel.
On the currency front, the
rupee appreciated 56 paise to settle at 75.04 against the US dollar.
No comments:
Post a Comment